Proapoptotic Activity and Chemosensitizing Effect of the Novel Akt Inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-amine (A443654) in T-Cell Acute Lymphoblastic Leukemia
dc.contributor.author | Fala, Federica | en_US |
dc.contributor.author | Blalock, William L. | en_US |
dc.contributor.author | Tazzari, Pier Luigi | en_US |
dc.contributor.author | Cappellini, Alessandra | en_US |
dc.contributor.author | Chiarini, Francesca | en_US |
dc.contributor.author | Martinelli, Giovanni | en_US |
dc.contributor.author | Tafuri, Agostino | en_US |
dc.contributor.author | McCubrey, James A. | en_US |
dc.contributor.author | Cocco, Lucio | en_US |
dc.contributor.author | Martelli, Alberto M. | en_US |
dc.date.accessioned | 2011-03-02T15:28:30Z | en_US |
dc.date.accessioned | 2011-05-17T01:40:03Z | |
dc.date.available | 2011-03-02T15:28:30Z | en_US |
dc.date.available | 2011-05-17T01:40:03Z | |
dc.date.issued | 2008-09 | en_US |
dc.description.abstract | Constitutively activated AKT kinase is a common feature of T-cell acute lymphoblastic leukemia (T-ALL). Here, we report that the novel AKT inhibitor (2S)-1-(1H-indol-3-yl)-3-[5-(3-methyl-2Hindazol-5-yl)pyridin-3-yl]oxypropan2-amine (A443654) leads to rapid cell death of T-ALL lines and patient samples. Treatment of CEM, Jurkat, and MOLT-4 cells with nanomolar doses of the inhibitor led to AKT phosphorylation accompanied by dephosphorylation and activation of the downstream target, glycogen synthase kinase-3â. Effects were time- and dose-dependent, resulting in apoptotic cell death. Treatment of Jurkat cells with A443654 resulted in activation of caspase-2, -3, -6, -8, and -9. Apoptotic cell death was mostly dependent on caspase-2 activation, as demonstrated by preincubation with a selective pharmacological inhibitor. It is remarkable that A443654 was highly effective against the drug-resistant cell line CEMVBL100, which expresses 170-kDa P-glycoprotein. Moreover, A443654 synergized with the DNA-damaging agent etoposide in both drug-sensitive and drug-resistant cell lines when coadministered [combination index (CI) = 0.39] or when pretreated with etoposide followed by A443654 (CI = 0.689). The efficacy of A443654 was confirmed using blasts from six patients with T-ALL, all of whom displayed low levels of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and constitutive phosphorylation of Akt on Ser473. At 1 ìM, the inhibitor was able to induce apoptotic cell death of T-ALL blast cells, as indicated by flow cytometric analysis of samples immunostained for active (cleaved) caspase-3. Because activated AKT is seen in a large percentage of patients with T-ALL, A443654, either alone or in combination with existing drugs, may be a useful therapy for primary and drug-resistant T-ALL. Originally published Molecular Pharmacology, Vol. 74, No. 3, Sep 2008 | en_US |
dc.identifier.citation | Molecular Pharmacology; 74:3 p. 884-895 | en_US |
dc.identifier.pmid | PMC2659779 | en_US |
dc.identifier.uri | http://hdl.handle.net/10342/3274 | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | East Carolina University | en_US |
dc.relation.uri | http://molpharm.aspetjournals.org/content/74/3/884.long | en_US |
dc.rights | Author notified of opt-out rights by Cammie Jennings. | en_US |
dc.subject | T-cell acute lymphoblastic leukemia | en_US |
dc.subject | Akt | en_US |
dc.subject | A443654 | en_US |
dc.title | Proapoptotic Activity and Chemosensitizing Effect of the Novel Akt Inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-amine (A443654) in T-Cell Acute Lymphoblastic Leukemia | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Proapopototic activity chemosensitizing effect.pdf
- Size:
- 842.4 KB
- Format:
- Adobe Portable Document Format